These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

423 related articles for article (PubMed ID: 32561657)

  • 21. Analysis of Measles-Mumps-Rubella (MMR) Titers of Recovered COVID-19 Patients.
    Gold JE; Baumgartl WH; Okyay RA; Licht WE; Fidel PL; Noverr MC; Tilley LP; Hurley DJ; Rada B; Ashford JW
    mBio; 2020 Nov; 11(6):. PubMed ID: 33219096
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Measles, mumps, rubella vaccine (Priorix; GSK-MMR): a review of its use in the prevention of measles, mumps and rubella.
    Wellington K; Goa KL
    Drugs; 2003; 63(19):2107-26. PubMed ID: 12962524
    [TBL] [Abstract][Full Text] [Related]  

  • 23. BCG-induced trained immunity: can it offer protection against COVID-19?
    O'Neill LAJ; Netea MG
    Nat Rev Immunol; 2020 Jun; 20(6):335-337. PubMed ID: 32393823
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Strong homology between SARS-CoV-2 envelope protein and a Mycobacterium sp. antigen allows rapid diagnosis of Mycobacterial infections and may provide specific anti-SARS-CoV-2 immunity via the BCG vaccine.
    Nuovo G; Tili E; Suster D; Matys E; Hupp L; Magro C
    Ann Diagn Pathol; 2020 Oct; 48():151600. PubMed ID: 32805515
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of Routine Infant BCG Vaccination on COVID-19.
    Kinoshita M; Tanaka M
    J Infect; 2020 Oct; 81(4):625-633. PubMed ID: 32795481
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stop playing with data: there is no sound evidence that Bacille Calmette-Guérin may avoid SARS-CoV-2 infection (for now).
    Riccò M; Gualerzi G; Ranzieri S; Bragazzi NL
    Acta Biomed; 2020 May; 91(2):207-213. PubMed ID: 32420947
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antibody persistence for 3 years following two doses of tetravalent measles-mumps-rubella-varicella vaccine in healthy children.
    Knuf M; Zepp F; Helm K; Maurer H; Prieler A; Kieninger-Baum D; Douha M; Willems P
    Eur J Pediatr; 2012 Mar; 171(3):463-70. PubMed ID: 21935584
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Progress in possible effects of BCG vaccine on the prevention of SARS-CoV-2 infection: An update].
    Huang W; Liu T; Feng G; Wang X
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2020 Nov; 36(11):1044-1048. PubMed ID: 33210600
    [TBL] [Abstract][Full Text] [Related]  

  • 29. COVID-19 vaccination clinical trials should consider multiple doses of BCG.
    Ayoub BM
    Pharmazie; 2020 Apr; 75(4):159. PubMed ID: 32295694
    [No Abstract]   [Full Text] [Related]  

  • 30. Protective effects of vaccinations and endemic infections on COVID-19: A hypothesis.
    Meenakshisundaram R; Senthilkumaran S; Thirumalaikolundusubramanian P
    Med Hypotheses; 2020 Oct; 143():109849. PubMed ID: 32480250
    [No Abstract]   [Full Text] [Related]  

  • 31. Implications of COVID-19 in pediatric rheumatology.
    Batu ED; Özen S
    Rheumatol Int; 2020 Aug; 40(8):1193-1213. PubMed ID: 32500409
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunogenicity and safety of a novel MMR vaccine (live, freeze-dried) containing the Edmonston-Zagreb measles strain, the Hoshino mumps strain, and the RA 27/3 rubella strain: Results of a randomized, comparative, active controlled phase III clinical trial.
    Sood A; Mitra M; Joshi HA; Nayak US; Siddaiah P; Babu TR; Mahapatro S; Sanmukhani J; Gupta G; Mittal R; Glueck R
    Hum Vaccin Immunother; 2017 Jul; 13(7):1523-1530. PubMed ID: 28362563
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Measles-Mumps-Rubella Vaccine and COVID-19 Relationship.
    Özdemir Ö
    mBio; 2020 Sep; 11(5):. PubMed ID: 32963005
    [No Abstract]   [Full Text] [Related]  

  • 34. Reactogenicity and immunogenicity of a new live attenuated combined measles, mumps and rubella vaccine in healthy children.
    Usonis V; Bakasenas V; Kaufhold A; Chitour K; Clemens R
    Pediatr Infect Dis J; 1999 Jan; 18(1):42-8. PubMed ID: 9951979
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Antibody persistence following on different vaccination strategies of domestic measles, mumps and rubella combined attenuated live vaccine: a 3-year follow-up study].
    He HQ; Li Q; Yan R; Zhou Y; Tang XW; Deng X; Xie SY; Chen ZP
    Zhonghua Yu Fang Yi Xue Za Zhi; 2017 Apr; 51(4):336-340. PubMed ID: 28395468
    [No Abstract]   [Full Text] [Related]  

  • 36. Immunogenicity and safety of measles-mumps-rubella vaccine at two different potency levels administered to healthy children aged 12-15 months: A phase III, randomized, non-inferiority trial.
    MMR-161 Study Group
    Vaccine; 2018 Sep; 36(38):5781-5788. PubMed ID: 30104117
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The influence of vaccination against tuberculosis with the Bacillus-Calmette-Guérin(BCG) vaccine on COVID-19 incidence and mortality - review of the literature.
    Ręka G; Korzeniowska A; Piecewicz-Szczęsna H
    Przegl Epidemiol; 2020; 74(2):290-302. PubMed ID: 33115218
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Open randomized trial comparing the immunogenicity and safety of a new measles-mumps-rubella vaccine and a licensed vaccine in 12- to 24-month-old children.
    Feiterna-Sperling C; Brönnimann R; Tischer A; Stettler P; Durrer P; Gaedicke G
    Pediatr Infect Dis J; 2005 Dec; 24(12):1083-8. PubMed ID: 16371870
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy and safety of vaccination of marrow transplant recipients with a live attenuated measles, mumps, and rubella vaccine.
    Ljungman P; Fridell E; Lönnqvist B; Bolme P; Böttiger M; Gahrton G; Linde A; Ringdén O; Wahren B
    J Infect Dis; 1989 Apr; 159(4):610-5. PubMed ID: 2647859
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CHRONOVAC VOYAGEUR: A study of the immune response to yellow fever vaccine among infants previously immunized against measles.
    Goujon C; Gougeon ML; Tondeur L; Poirier B; Seffer V; Desprès P; Consigny PH; Vray M;
    Vaccine; 2017 Oct; 35(45):6166-6171. PubMed ID: 28958813
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.